openPR Logo
Press release

Incredible Growth of Human Growth Hormone Market Size, Share, Trends, Analysis and Forecast 2027| Pfizer Inc., Genetech Inc., Merck & Co., Eli Lilly And Company, Novo Nordisk, Sandoz International GmbH, Ferring Holding SA, and Ipsen.

05-05-2020 05:02 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Human Growth Hormone Market

Human Growth Hormone Market

The "Global Human Growth Hormone Market: 2020" Industry Report is a professional and in-depth study on the current state of the Human Growth Hormone Market by CMI. The Human Growth Hormone market is supposed to demonstrate a considerable growth during the forecast period of 2020 - 2027. The company profiles of all the key players and brands that are dominating the market have been given in this report. Their moves like product launches, joint ventures, mergers and acquisitions and the respective effect on the sales, import, export, revenue and CAGR values have been studied completely in the report. The scope of this Human Growth Hormone market report can be expanded from market scenarios to comparative pricing between major players. The emerging trends along with major drivers, challenges and opportunities in the market are also identified and analysed in this report.

Human Growth Hormone help organizations to develop cogent, coherent plans of action to improve their performance.

To Gain More Insights into the Market with Detailed Table of Content and Figures, Click Here -https://www.coherentmarketinsights.com/ongoing-insight/human-growth-hormone-market-1859

Human growth hormone is a peptide hormone that is naturally produced in the pituitary glands. It stimulates growth, cell reproduction, and cell regeneration. The somatotropic cells within the lateral wings of anterior pituitary gland store and secrete growth hormone. These hormones are responsible for general growth of the body and mineralization of the bones. Growth hormones also help to retain calcium in the body and increases muscle mass through sarcomere hypertrophy. The hormones promote lipolysis, increase protein synthesis, and stimulate growth of all internal organs excluding the brain. Growth hormones are responsible for homeostasis, decrease in uptake of glucose by liver, stimulation in the immune system, and increase of DE iodination of T4 to T3.

However, uncontrolled or excess secretion of growth hormones can lead to pituitary tumor, which consists of somatotroph cells of the anterior pituitary. These somatotroph cells are benign in nature and gradually grow and produce excess of growth hormones. This may often lead to headaches, pressure on optic nerves causing impaired vision, deficiency of other hormones secreted by pituitary gland, and thickening of the bones of jaw, toes, and fingers, which eventually results in heaviness of jaws and increase in size of digits called as acromegaly. Acromegaly can further lead to pressure on nerves, muscle weakness, and reduced sexual function. Growth hormone deficiency is associated with failure in growth, increase in osteoclast activities, weakening of bones, trauma, increase in fat mass, and decrease in muscle mass.

Request a PDF Sample Copy of the Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1859

This report sample includes
--Brief Introduction to the research report.
--Table of Contents (Scope covered as a part of the study)
--Top players in the market
--Research framework (presentation)
--Research methodology adopted by Coherent Market Insights

Human Growth Hormone Market Drivers:-

Key players in the market are focused on adopting merger and acquisition strategies, which is expected to boost growth of the market. For instance, in 2014, Pfizer Inc., a U.S.-based pharmaceutical company, merged with OPKO Health Inc., a U.S.-based company, to develop a long acting growth hormone (hGH-CTP) and to bring innovative treatments for growth hormone deficient patients. hGH-CTP is more convenient, as the patients need to take just one injection in a week rather than daily doses. hGH-CTP has an orphan drug designation in the U.S. and Europe for adults and children with growth hormone deficiency.

Robust pipeline of advanced products for the treatment of growth hormone deficiency is also expected to propel growth of the market. For instance, Somapacitan sponsored by Novo Nordisk A/S, a Denmark-based company, completed phase 3 clinical trials in 2017. This drug is used for the treatment of growth hormone deficiency in adults. MOD-4023 sponsored by Opko Biologics, an Israel-based company, completed phase 2 clinical trials in 2015. High prevalence of growth hormone deficiency is another factor boosting growth of human growth hormone market. According to a survey conducted by the National Organization for Rare Diseases (NORA) in 2015, over 10,000 children and 50,000 adults have growth hormone deficiency in the U.S.

However, stringent rules and regulations for the use of human growth hormone is expected to hamper the market growth. For instance, in 2006, the U.S. Food and Drug Administration (FDA) and the International Olympic Committee banned the use of human growth hormone for sports professionals.

The key players profiled in this report include:
-Pfizer Inc.
-Genetech Inc.
-Merck & Co.
-Eli Lilly And Company
-Novo Nordisk
-Sandoz International GmbH
-Ferring Holding SA
-Ipsen.

Regions included:

o North America (United States, Canada, and Mexico)
o Europe (Germany, France, UK, Russia, and Italy)
o Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
o South America (Brazil, Argentina, Colombia)
o Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Human Growth Hormone Market Taxonomy:-
By Application
o Growth Hormone Deficiency
o Idiopathic short stature
o Prader-Willi Syndrome
o Turner Syndrome
o Others

By Route of Administration
o Oral
o Intravenous
o Subcutaneous
o Intramuscular

By Distribution Channel
o Hospitals
o Retail Pharmacies
o Online Pharmacies

Human Growth Hormone Market Regional Analysis:-

North America is expected to hold dominant position in the global human growth hormone market. This is attributed to approval of new biosimilars. For instance, in 2015, Health Canada approved the first generic biological called as PROmnitrope. PROmnitrope is a recombinant human growth hormone used to treat deficiency of growth hormone in adults as well as children. This can encourage new generic version of drugs, thereby fueling the human growth hormone market growth.

Buy This Research Study Report @ https://www.coherentmarketinsights.com/insight/buy-now/1859

Key players in the Europe market are focused on adopting merger and acquisition strategies, which is expected to contribute to growth of the market. For instance, in 2017, Ferring Pharmaceuticals S.A., a pharmaceutical company, acquired a product i.e. Zoma Jet of Antares Pharma Inc, a pharmaceutical company. Zoma Jet is a needle free auto injectable device. Ferring Pharmaceuticals S.A acquired Zoma Jet in order to increase use of Zomacton (Injectable somatropin hGH). Zoma Jet is used to deliver Zomacton for the treatment of growth hormone deficiency in children and Turner's syndrome in girls. By acquiring the injectable device Zoma Jet, would eventually lead to increase in use of the drug, Zomacton, which will further encourage Ferring Pharmaceuticals to develop better treatment options for growth hormone deficiency, thereby resulting in growth of the human growth hormone market. Asia Pacific is expected to grow over the forecast period due to robust pipeline. For instance, Cinna Tropin sponsored by Cinnagen, an Iran-based company, completed phase 3 clinical trials in 2017. This drug is used to treat idiopathic short stature in children and adults.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
[email protected]

U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Incredible Growth of Human Growth Hormone Market Size, Share, Trends, Analysis and Forecast 2027| Pfizer Inc., Genetech Inc., Merck & Co., Eli Lilly And Company, Novo Nordisk, Sandoz International GmbH, Ferring Holding SA, and Ipsen. here

News-ID: 2034975 • Views: 670

More Releases from Coherent Market Insights

Health Caregiving Market to See Booming Growth | Honor Technology, Inc., Vesta H …
A new business intelligence report released by CMI with title “Global Health Caregiving Market Insights, Forecast to 2027” The analysts of the study have garnered extensive research methodologies and data sources (i.e. Secondary & Primary Sources) in order to generate collective and useful information that delivers latest market undercurrents and industry trends. If you are involved in the Global Health Caregiving industry or intend to be, then this study will provide
Neuropathic Pain Market Analysis & Trends by 2027 | Pfizer, Inc., Johnson & John …
A new business intelligence report released by CMI with title “Global Neuropathic Pain Market Insights, Forecast to 2027” The analysts of the study have garnered extensive research methodologies and data sources (i.e. Secondary & Primary Sources) in order to generate collective and useful information that delivers latest market undercurrents and industry trends. If you are involved in the Global Neuropathic Pain industry or intend to be, then this study will provide
Residential Intellectual Disability Facilities Market May Set New Growth Story: …
A new business intelligence report released by CMI with title “Global Residential Intellectual Disability Facilities Market Insights, Forecast to 2027” The analysts of the study have garnered extensive research methodologies and data sources (i.e. Secondary & Primary Sources) in order to generate collective and useful information that delivers latest market undercurrents and industry trends. If you are involved in the Global Residential Intellectual Disability Facilities industry or intend to be, then
Regenerative Artificial Skin Market Analysis & Trends by 2026| Integra Life Scie …
A new business intelligence report released by CMI with title “Global Regenerative Artificial Skin Market Insights, Forecast to 2027” The analysts of the study have garnered extensive research methodologies and data sources (i.e. Secondary & Primary Sources) in order to generate collective and useful information that delivers latest market undercurrents and industry trends. If you are involved in the Global Regenerative Artificial Skin industry or intend to be, then this study

All 5 Releases


More Releases for Human

Human Physiology 2019
Human Physiology 2019 Theme: Exploring the Principles of Physiology & Metabolism September 16-17, 2019 | London, United Kingdom Lexis Conferences cordially invites all the members of different nations to attend this annual meet which is scheduled to hold on September 16-17, 2019 at London, United Kingdom based on theme Exploring the Principles of Physiology & Metabolism. A two days scientific meet will gather scientists, students and healthcare industries under one roof to build
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
metamorphis the Human Story
contact: Rosalyn Lifshin, Executive Director Ocean City Arts Center, [email protected] (609) 399-7628
Human Resources or Human Capital?
Are people really an organisation's most important asset? Not necessarily. Some are liabilities – but some undoubtedly are the most important drivers of value that an organisation has. The question is – who are they? How do we know? How can we maximise the value they have and the value they provide? These questions are what human capital management is about. This book explains the answers and discusses approaches
男女做爰高清免费视频-骚虎视频-4虎视频